Delirium Clinical Trial
— IPOD-B3Official title:
Interventions for Postoperative Delirium: Biomarker-3
The IPOD-B3 study aims to characterize the relationship between premorbid brain activity and postoperative delirium in patients undergoing major surgery. This is a expansion of the NeuroVISION Bolt-On study, NCT01980511.
Status | Recruiting |
Enrollment | 310 |
Est. completion date | December 2025 |
Est. primary completion date | December 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 65 Years and older |
Eligibility | Inclusion Criteria: - Age =65 years - Anticipated length of hospital stay of at least 2 days after surgery that occurs under general or neuraxial anesthesia - Written Informed Consent for potential participation prior to surgery Exclusion Criteria: - Contraindication to EEG - Unable or unwilling to attend the follow-up appointments - Documented history of dementia - Deemed incapable of providing consent by surgical team - Residing in a nursing home - Undergoing intracranial surgery - Unable to complete neurocognitive testing due to language, vision or hearing impairment - Unable to communicate with the research staff due to language barriers - For optional MRI portion of the study: Contraindication to MRI (e.g., implanted devices not safe for MRI studies, claustrophobia, unable to lie flat or still) |
Country | Name | City | State |
---|---|---|---|
United States | University of Wisconsin-Madison | Madison | Wisconsin |
Lead Sponsor | Collaborator |
---|---|
University of Wisconsin, Madison | National Institute on Aging (NIA) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Functional Connectivity | Change from baseline functional connectivity at immediate postoperative period and association between delirium (CAM) and functional connectivity of the cingulate cortex | Pre-operative measure: Up to 4 weeks prior to surgery. Post-operative measure: Post-Operative days 1-4 | |
Secondary | Inflammation | Assess the changes from preoperative to postoperative EEG associated with delirium and change in plasma/cerebrospinal fluid (CSF) IL-6 or other biomarkers (e.g. other cytokines or markers of neronal injury) | Pre-operative measure: Up to 4 weeks prior to surgery. Post-operative measure: POD1-4 | |
Secondary | Biomarkers | Identify biomarkers of delirium and neural damage through changes in circulating plasma proteins and molecules (through mass spectometry) | Post-operative day 1 through 4 | |
Secondary | Brain measurements | Assess the association between preoperative white matter connectivity (DTI) and cortical thickness (derived from MRI) and postoperative delirium | Preoperative MRI will occur up to 4-weeks prior to surgery. Delirium is followed postoperatively, days 1-4 | |
Secondary | Long term cognition | Examine the incidence of delirium with change in cognition from preoperatively to one-year postoperatively. | Pre-operative cognition measures will occur up to 4 weeks prior to surgery. Post-operative delirium measured on postoperative days 1-4. Long term post-operative cognition measured 1 year after surgery. | |
Secondary | Long term cognition | Assess the impact of delirium, preoperative and postoperative imaging biomarkers with a change in long term cognition | Pre-operative measure: Up to 4 weeks prior to surgery. Post-operative measure: Up to two years after surgery | |
Secondary | Baseline cognition, specific and global. | Examine the association between preoperative cognition using a neuropsychological battery, and postoperative delirium incidence. | Cognition is assessed preoperatively. Participants are followed for delirium on postoperative days 1-4 | |
Secondary | Biomarkers and brain measurements | Assess the changes in cognition and biomarkers over one year with EEG changes. | Pre-op measures: up to 4 weeks prior to surgery. Post-op measures: one year, and two years, after surgery. | |
Secondary | Representativeness of surgical population | Identify whether patients who consent to the MRI are reflective of the surgical population. | Pre-op MRI: up to 4 weeks prior to surgery. | |
Secondary | Genetics and delirium | Identify genetic and epigenetic changes associated with delirium and its pathogenesis. | Pre-op blood collected up to 4 weeks prior to surgery. Post-operative delirium measured on postoperative days 1-4. Post-operative blood collected on postoperative days 1-4. Long term blood collected 90 days and 1 year after surgery. | |
Secondary | Postoperative amyloid beta deposition and delirium | Identify associations between delirium and amyloid beta deposition detected by Positron Emission Tomography at 90 days after surgery in sub-study IPOD-PET. | Post-operative delirium measured on postoperative days 1-4. PET imaging will occur 90 days after surgery. | |
Secondary | Long term changes in amyloid beta deposition and delirium | Identify associations between delirium and amyloid beta deposition detected by Positron Emission Tomography preoperatively and 1 year after surgery in sub-study IPOD-PET2. | Pre-operative PET imaging will occur up to 4 weeks prior to surgery. Post-operative delirium measured on postoperative days 1-4. Post-operative PET imaging will occur 1 year after surgery. | |
Secondary | Long term cognition | Identify predictors of delirium severity and incidence, for change in cognition from preoperatively to two-years postoperatively. | Pre-operative cognition measures will occur up to 4 weeks prior to surgery. Long term post-operative cognition measured 2 years after surgery. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04551508 -
Delirium Screening 3 Methods Study
|
||
Recruiting |
NCT05891873 -
Delirium in the (Neuro)Intensive/Critical Care in the Adult and Paediatric Czech Populations
|
||
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Recruiting |
NCT04792983 -
Cognition and the Immunology of Postoperative Outcomes
|
||
Recruiting |
NCT06194474 -
Study on Biomarkers of Postoperative Delirium in Elderly Cardiac Surgery Patients
|
||
Completed |
NCT03095417 -
Improving the Recovery and Outcome Every Day After the ICU
|
N/A | |
Completed |
NCT05395559 -
Prevalence and Recognition of Cognitive Impairment in Hospitalized Patients: a Flash Mob Study
|
||
Terminated |
NCT03337282 -
Incidence and Characteristics of Postoperative Cognitive Dysfunction in Elderly Quebec Francophone Patients
|
||
Not yet recruiting |
NCT04846023 -
Pediatric Delirium Screening in the PICU Via EEG
|
N/A | |
Not yet recruiting |
NCT04538469 -
Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
|
||
Not yet recruiting |
NCT03807388 -
ReMindCare App for Patients From First Episode of Psychosis Unit.
|
N/A | |
Withdrawn |
NCT02673450 -
PER3 Clock Gene Polymorphism, Clock Gene Expression and Delirium in the Intensive Care Unit.
|
||
Recruiting |
NCT03256500 -
Transcranial Direct Current Stimulation for the Treatment of Delirium
|
N/A | |
Completed |
NCT02890927 -
Geriatric-CO-mAnagement for Cardiology Patients in the Hospital
|
N/A | |
Not yet recruiting |
NCT02892968 -
ED Ultrasonographic Regional Anesthesia to Prevent Incident Delirium in Hip Fracture Patients
|
N/A | |
Recruiting |
NCT03165539 -
Cerebral Oxygen Desaturation and Post-Operative Delirium in Thoracic Surgical Patients
|
||
Completed |
NCT02554253 -
The Impact of Ketamine on Postoperative Cognitive Dysfunction, Delirium, and Renal Dysfunction
|
Phase 2 | |
Completed |
NCT02518646 -
DElirium prediCtIon in the intenSIve Care Unit: Head to Head comparisON of Two Delirium Prediction Models
|
N/A | |
Recruiting |
NCT02305589 -
The Clinical Changes Before and After Sugammadex in the Patients Undergoing Hip Surgery on the Aspect of Delirium
|
N/A | |
Completed |
NCT02628925 -
Nu-DESC DK: The Danish Version of the Nursing Delirium Screening Scale
|
N/A |